ResMed announced today that it launched the AirFit F40 ultra-compact, full-face mask for sleep apnea. San Diego-based ResMed designed AirFit F40 to offer the comfort of smaller masks without sacrificing performance. This could, in turn, help with sleep apnea therapy compliance for users of high-pressure continuous positive airway pressure (CPAP) treatment. According to a news […]
ResMed
ResMed launches new bilevel sleep respiratory devices
ResMed announced today that it launched its AirCurve 11 series bilevel positive airway pressure devices in the U.S. San Diego-based ResMed describes the AirCurve 11 series as its newest range of bilevel devices that use two levels of support. They use inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). Combined with digital […]
ResMed stock rises on Street-beating Q2
ResMed shares ticked up today on second-quarter results that came in ahead of the consensus forecast. Shares of RMD increased by 6.6% to $183.16 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose by 1%. The San Diego-based sleep respiratory device maker […]
ResMed CPAP masks recall is Class I
The FDA announced that ResMed’s voluntary recall of millions of CPAP mask magnets is now Class I, the agency’s most serious level. Last month, ResMed warned CPAP users about potential magnetic interference when magnets go near certain implants and medical devices in the body. People using CPAP masks with magnets only need to return […]
ResMed warns on updates to masks with magnets
ResMed announced today that it’s conducting a voluntary global field action to update guides for all masks with magnets. San Diego-based ResMed informed users of potential magnetic interference when magnets go near certain implants and medical devices in the body. The company doesn’t require a return of a mask with magnets unless the patient is […]
ResMed earns victory in patent spat with NYU
ResMed announced that it secured a victory in a patent battle with New York University. The San Diego-based respiratory device maker said the U.S. Patent Trial and Appeals Board (PTAB) invalidated NYU claims against ResMed. These claims came based on seven NYU patents. In June 2021, NYU filed a complaint for patent infringement against ResMed […]
ResMed has a new operating model following recent layoffs
ResMed announced that it’s implementing a new operating model to accelerate long-term growth. San Diego-based ResMed’s operational shift follows a recent restructuring effort that included a 5% workforce reduction. The new operating model introduces dedicated leadership in product, revenue and marketing to the company’s executive team. It includes a series of executive moves within the […]
ResMed is cutting its workforce as it seeks to refocus
ResMed announced that it is reducing its workforce by about 5% as part of a restructuring it plans to complete in the present quarter. The San Diego–based maker of CPAPs and other respiratory devices listed a headcount of 8,160 in its most recent annual report, which means roughly 400 workers could be affected. “Decisions like […]
ResMed shares near 52-week low after disappointing results
ResMed shares are down on fourth-quarter sales and profits that missed Wall Street’s expectations. The device manufacturer’s stock was trading around $183.58 per share near noon, approaching the 52-week low of $181.50. The stock hasn’t closed below $188 since April 2021, when competitor Philips initiated a recall of millions of continuous positive airway pressure (CPAP) […]
ResMed acquires respiratory diagnostics software developer Somnoware
ResMed announced that it acquired respiratory care diagnostics software developer Somnoware. This move marks the second software buy in the past year for ResMed. The San Diego-based sleep respiratory treatment maker bought Medifox Dan for $1 billion in November 2022. Medifox Dan develops clinical, financial and operational software for out-of-hospital care providers. It offers care […]
ResMed studies show how PAP adherence reduces hospitalizations
ResMed today announced two studies highlighting the benefits of positive airway pressure (PAP) therapy adherence. The studies demonstrated reductions in hospitalizations and emergency room visits, as well as costs, thanks to PAP therapy adherence. ResMed presented the study, which evaluated people with heart failure and obstructive sleep apnea (OSA), at SLEEP 2023 in Indianapolis. One […]